MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. AAPL
4. SPGI
5. USO
6. DELL
7. ENOV
8. AON
9. NIO
10. EIX

Go back to MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
MACROGENICS (NASDAQ: MGNX) Delayed: 4.04 +0.05 (1.25%)
Previous Close $3.99    52 Week High $36.11 
Open $3.98    52 Week Low $14.84 
Day High $4.10    P/E 10.36 
Day Low $3.89    EPS $0.39 
Volume 499,893